XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
26.98
+0.22 (0.82%)
Jan 21, 2025, 4:00 PM EST - Market closed
XOMA Royalty Employees
XOMA Royalty had 13 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,662,000
Profits / Employee
-$2,725,692
Market Cap
317.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
XOMA News
- 4 weeks ago - XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewsWire
- 2 months ago - XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities - GlobeNewsWire
- 3 months ago - XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience - GlobeNewsWire
- 3 months ago - Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash - Business Wire
- 3 months ago - XOMA Royalty's Preferred Shares: High-Yield Dividends From Biotech Royalties - Seeking Alpha
- 3 months ago - I Am Banking On The Silver Tsunami With Big Dividends - Seeking Alpha
- 3 months ago - XOMA Stock Dips Amidst Biotech Sector Decline - GuruFocus
- 4 months ago - Zevra's MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC) - GlobeNewsWire